Cargando…
Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry
INTRODUCTION: Transcatheter aortic valve implantation (TAVI) is a less invasive treatment option for elderly, high-risk patients with symptomatic severe aortic stenosis (AS) than aortic valve replacement. More importantly, TAVI improves survival and quality of life as compared to medical treatment i...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882384/ https://www.ncbi.nlm.nih.gov/pubmed/27279871 http://dx.doi.org/10.5114/aic.2016.59362 |
_version_ | 1782434109126082560 |
---|---|
author | Bagienski, Maciej Kleczynski, Pawel Dziewierz, Artur Rzeszutko, Lukasz Sorysz, Danuta Trebacz, Jaroslaw Sobczynski, Robert Tomala, Marek Stapor, Maciej Gackowski, Andrzej Dudek, Dariusz |
author_facet | Bagienski, Maciej Kleczynski, Pawel Dziewierz, Artur Rzeszutko, Lukasz Sorysz, Danuta Trebacz, Jaroslaw Sobczynski, Robert Tomala, Marek Stapor, Maciej Gackowski, Andrzej Dudek, Dariusz |
author_sort | Bagienski, Maciej |
collection | PubMed |
description | INTRODUCTION: Transcatheter aortic valve implantation (TAVI) is a less invasive treatment option for elderly, high-risk patients with symptomatic severe aortic stenosis (AS) than aortic valve replacement. More importantly, TAVI improves survival and quality of life as compared to medical treatment in inoperable patients. AIM: To assess early- and mid-term clinical outcomes after TAVI. MATERIAL AND METHODS: All consecutive high-risk patients with severe symptomatic AS undergoing TAVI from November 2008 to August 2014 were enrolled. The clinical and procedural characteristics, as well as clinical outcomes including mortality during 12-month follow-up, were assessed. RESULTS: A total of 101 consecutive patients underwent TAVI for native aortic valve stenosis (100%). Patients were elderly, with a median age of 81.0 (76.0–84.0) years, 60.4% were female and 83.2% presented with NYHA III/IV. Median baseline EuroSCORE I and STS scores were 14.0 (10.0–22.5)% and 12.0 (5.0–24.0)%, respectively. The main periprocedural and in-hospital complications were minor vascular complications, bleeding requiring blood transfusions, and the need for a permanent pacemaker. In-hospital, 30-day, 6-month and 12-month mortality rates were 6.9%, 10.9%, 15.8% and 17.8%, respectively. CONCLUSIONS: A mortality rate of < 20% after 12 months seems acceptable given the high-risk population enrolled. |
format | Online Article Text |
id | pubmed-4882384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-48823842016-06-08 Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry Bagienski, Maciej Kleczynski, Pawel Dziewierz, Artur Rzeszutko, Lukasz Sorysz, Danuta Trebacz, Jaroslaw Sobczynski, Robert Tomala, Marek Stapor, Maciej Gackowski, Andrzej Dudek, Dariusz Postepy Kardiol Interwencyjnej Original Paper INTRODUCTION: Transcatheter aortic valve implantation (TAVI) is a less invasive treatment option for elderly, high-risk patients with symptomatic severe aortic stenosis (AS) than aortic valve replacement. More importantly, TAVI improves survival and quality of life as compared to medical treatment in inoperable patients. AIM: To assess early- and mid-term clinical outcomes after TAVI. MATERIAL AND METHODS: All consecutive high-risk patients with severe symptomatic AS undergoing TAVI from November 2008 to August 2014 were enrolled. The clinical and procedural characteristics, as well as clinical outcomes including mortality during 12-month follow-up, were assessed. RESULTS: A total of 101 consecutive patients underwent TAVI for native aortic valve stenosis (100%). Patients were elderly, with a median age of 81.0 (76.0–84.0) years, 60.4% were female and 83.2% presented with NYHA III/IV. Median baseline EuroSCORE I and STS scores were 14.0 (10.0–22.5)% and 12.0 (5.0–24.0)%, respectively. The main periprocedural and in-hospital complications were minor vascular complications, bleeding requiring blood transfusions, and the need for a permanent pacemaker. In-hospital, 30-day, 6-month and 12-month mortality rates were 6.9%, 10.9%, 15.8% and 17.8%, respectively. CONCLUSIONS: A mortality rate of < 20% after 12 months seems acceptable given the high-risk population enrolled. Termedia Publishing House 2016-05-11 2016 /pmc/articles/PMC4882384/ /pubmed/27279871 http://dx.doi.org/10.5114/aic.2016.59362 Text en Copyright © 2016 Termedia http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Original Paper Bagienski, Maciej Kleczynski, Pawel Dziewierz, Artur Rzeszutko, Lukasz Sorysz, Danuta Trebacz, Jaroslaw Sobczynski, Robert Tomala, Marek Stapor, Maciej Gackowski, Andrzej Dudek, Dariusz Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry |
title | Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry |
title_full | Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry |
title_fullStr | Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry |
title_full_unstemmed | Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry |
title_short | Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry |
title_sort | early- and mid-term outcomes after transcatheter aortic valve implantation. data from a single-center registry |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882384/ https://www.ncbi.nlm.nih.gov/pubmed/27279871 http://dx.doi.org/10.5114/aic.2016.59362 |
work_keys_str_mv | AT bagienskimaciej earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT kleczynskipawel earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT dziewierzartur earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT rzeszutkolukasz earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT soryszdanuta earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT trebaczjaroslaw earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT sobczynskirobert earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT tomalamarek earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT stapormaciej earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT gackowskiandrzej earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry AT dudekdariusz earlyandmidtermoutcomesaftertranscatheteraorticvalveimplantationdatafromasinglecenterregistry |